Medtronic logo

Medtronic

MDT | NYSE
Chart Builder DCF Calculator
$96.54
-$0.57 (-0.59%)
At close: Oct 30, 2026, 4:00 PM ET
$96.44
-$0.10 (-0.10%)
Pre-market: Nov 2, 2026, 4:03 AM ET

Company Profile

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Key Executives

Name Position
Geoffrey Straub Martha Chairman of the Board & Chief Executive Officer
Thierry Pieton Executive Vice President & Chief Financial Officer
Alan Cheng Chief Medical Officer of Cardiac Rhythm Management
Alex Gu Senior VP & President of Greater China Region
Austin L. Chiang Chief Medical Officer Gastrointestinal Business
Brett A. Wall Executive Officer
Dave Moeller Senior VP & President of the Peripheral Vascular Health Operating Unit
Denise L. Blomquist Vice President, Global Controller & Chief Accounting Officer
Harry Kiil Executive Vice President & President of Cardiovascular Portfolio
Ingrid Goldberg Vice President & Head of Investor Relations
Jason Weidman Senior VP and President of Coronary & Renal Denervation business
Kweli Thompson Executive Vice President & President of Neuroscience Portfolio
Laura Mauri Senior Vice President and Chief Scientific & Medical Officer
Linnea Burman Senior VP and President of Medtronic's Neurovascular business
Matthew Walter Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing
Michael Marinaro Executive VP and President of Medical Surgical Portfolio & Americas
Michelle Quinn Executive Vice President, General Counsel & Secretary
Robert Adam Hopkins Senior Vice President & Head of Global Strategy
Robert Kowal VP & GM of Cardiac Pacing Therapies
Rogerio Branco SVP & Chief Operations and Supply Chain Officer
Sally Saba Chief Inclusion & Diversity Officer

Latest SEC Filings

Date Type Title
Oct 02, 2026 425 Filing
Oct 01, 2026 425 Filing
Sep 30, 2026 425 Filing
Sep 29, 2026 425 Filing
Sep 28, 2026 425 Filing
Sep 25, 2026 425 Filing
Sep 25, 2026 425 Filing
Sep 24, 2026 425 Filing
Sep 23, 2026 425 Filing
Sep 22, 2026 425 Filing
View All SEC Filings ➞
Medtronic
Medtronic logo
Country Ireland
IPO Date May 2, 1973
Industry Medical - Devices
Sector Healthcare
Employees 95,000
CEO Geoffrey Straub Martha

Contact Details

Building Two, Parkmore Business Park West Galway, Georgia H91 4K49 Ireland

Stock Details

Ticker Symbol MDT
Exchange NYSE
Fiscal Year May - April
Reporting Currency USD
CIK Code 0001613103
CUSIP Number G5960L103
ISIN Number IE00BTN1Y115
SIC Code 3845

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.